Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT study)

被引:12
作者
Nordenstedt, Helena
Nilsson, Magnus
Johnsen, Roar
Lagergren, Jesper
Hveem, Kristian
机构
[1] Karolinska Univ Hosp, Dept Mol Med & Surg, Karolinska Inst, Unit Esophageal & Gastr Res,ESOGAR, SE-17176 Stockholm, Sweden
[2] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway
[3] HUNT Res Ctr, Verdal, Norway
关键词
gastroesophageal reflux; Helicobacter pylori; gastric atrophy; cagA; population-based;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Backgrounds It has been suggested that Helicobacter pylori infection may prevent gastroesophageal reflux, possibly through gastric atrophy. Since, however, previous results are contradictory and no population-based studies are available, the relationship between H. pylori and reflux remains uncertain. The aim of this study was to investigate this relationship in a population-based, nested, case-control study. Methods From a cohort of 65,363 individuals, representing 71.2% of the adult population in the Norwegian county of Nord-Trondelag, we randomly selected 472 persons with recurrent reflux symptoms (cases) and 472 without such symptoms (controls). Occurrence of H. pylori and its virulence factor cagA was determined serologically, using an immunoblot assay. Gastric atrophy was assessed through serum levels of pepsinogen I. Odds ratios (OR) with 95% confidence intervals (CI), adjusted for potential confounding factors, represented relative risks. Results H. pylori infection was not associated with a decreased risk of reflux symptoms (OR 1.1, 95% CI 0.8-1.6), irrespective of positive cagA status (OR 1.1, 95% CI 0.8-1.5). Gastric atrophy reduced the risk of reflux symptoms (OR 0.2, 95% CI 0.0-0.6). Infection with H. pylori entailed a ninefold increase in the risk of gastric atrophy compared to non-infection (OR 8.9, 95% CI 2.0-39.9). Conclusions H. pylori infection, irrespective of cagA status, did not affect the occurrence of reflux symptoms in this population-based setting. Infected individuals are at increased risk of gastric atrophy, which in turn reduces reflux symptoms, but due to the low frequency of gastric atrophy among infected individuals overall, there was no association with reflux symptoms on a population level.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 38 条
[1]
The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden [J].
Agréus, L ;
Borgquist, L .
PHARMACOECONOMICS, 2002, 20 (05) :347-355
[2]
THE COHORT EFFECT AND HELICOBACTER-PYLORI [J].
BANATVALA, N ;
MAYO, K ;
MEGRAUD, F ;
JENNINGS, R ;
DEEKS, JJ ;
FELDMAN, RA .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (01) :219-221
[3]
BLASER MJ, 1995, CANCER RES, V55, P2111
[4]
RETRACTED: Meta-analysis:: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease (Retracted Article. See vol 19, p 145, 2004) [J].
Cremonini, F ;
Di Caro, S ;
Delgado-Aros, S ;
Sepulveda, A ;
Gasbarrini, G ;
Gasbarrini, A ;
Camilleri, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (03) :279-289
[5]
DeVault KR, 1999, AM J GASTROENTEROL, V94, P1434
[6]
Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO
[7]
2-2
[8]
Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels [J].
Di Mario, F ;
Ingegnoli, A ;
Altavilla, N ;
Cavallaro, LG ;
Bertolini, S ;
Merli, R ;
Cavestro, GM ;
Iori, V ;
Maino, M ;
Leandro, G ;
Franzè, A .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2005, 19 (04) :497-501
[9]
Opposing time trends of peptic ulcer and reflux disease [J].
El-Serag, HB ;
Sonnenberg, A .
GUT, 1998, 43 (03) :327-333
[10]
Corpus gastritis is protective against reflux oesophagitis [J].
El-Serag, HB ;
Sonnenberg, A ;
Jamal, MM ;
Inadomi, JM ;
Crooks, LA ;
Feddersen, RM .
GUT, 1999, 45 (02) :181-185